Type of Cancer
Leukemia
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML) Previously Treated with Hypomethylating Agents
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.